ABBV vs A
By Alex · Tickerpine
AbbVie Inc. vs Agilent Technologies, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | A |
|---|---|---|
| Price | $253.35 | $136.01 |
| Market cap | $447.62B | $38.41B |
| P/E ratio | 123.6 | 27.3 |
| ROE | — | 21.33% |
| Profit margin | 5.79% | 19.55% |
| Revenue growth | 12.40% | 10.00% |
| Dividend yield | 2.73% | 0.75% |
| Beta | 0.31 | 1.26 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs A in plain English
- ABBV is the bigger company — about 11.7× the market cap of A.
- A is cheaper on earnings (P/E 27.3 vs 123.6).
- ABBV is growing revenue faster (12% vs 10%).
- ABBV has the higher dividend yield (2.73% vs 0.75%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
A return calculator
See what $1,000 in Agilent Technologies, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.